FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/29/2026
Back to search
Official data from USPTO
LNJ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 42
Filing date
05/02/2024
Registration date
06/10/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/10/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
KR
Examiner
POWERS, ALEXANDER L
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
L&J Bio Co.,Ltd.
Representatives
Yan Song AEON Law, PLLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of brain disease using technology capable of passing through the blood-brain barrier to deliver therapeutic proteins directly to brain tissueusing the dual action therapy platform for medical purposes; pharmaceutical preparations for the treatment of Alzheimer's disease; pharmaceutical preparations for the treatment of brain disease for medical purposes; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of neurodegenerative brain diseases for medical purposes; pharmaceutical preparations for the treatment of Parkinson's disease; none of the foregoing related to the treatment of vaccinia and orthopox viruses
Class 42
Scientific research in the nature of conducting clinical trials for others in the field of brain and central nervous system diseases; research and development of vaccines and medicines; development of cell therapy products; drug discovery services; scientific research for medical purposes in the area of cancerous diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research laboratory services for predicting disease; medical research laboratory services in the field of the blood-brain barrier; medical research laboratory services in the field of Alzheimer's disease; none of the foregoing related to the treatment of vaccinia and orthopox viruses
Publications
History of USPTO decisions and trademark events.
30 publications found
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/22/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/13/2026
FIMP
FINAL DISPOSITION PROCESSED
01/13/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/07/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/07/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/10/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/10/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
06/10/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
05/18/2025
CHPB
POST PUBLICATION AMENDMENT - ENTERED
04/17/2025
APET
ASSIGNED TO PETITION STAFF
04/17/2025
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
03/13/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
02/06/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2025
PUBO
PUBLISHED FOR OPPOSITION
01/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2025
RFNT
REFUSAL PROCESSED BY IB
12/21/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/11/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/04/2024
RFRR
REFUSAL PROCESSED BY MPU
12/04/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/19/2024
CNRT
NON-FINAL ACTION WRITTEN
11/18/2024
DOCK
ASSIGNED TO EXAMINER
11/16/2024
MAFR
APPLICATION FILING RECEIPT MAILED
08/19/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/19/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/08/2024
Continuous trademark protection
Get notified about every new filing that threatens LNJ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.